The First 72 Hours After Your First Injection: A Clinician's Hour-by-Hour Guide

You pressed the plunger, capped the pen, and set it down. Now your brain is running a background scan on every sensation in your body. That flutter in your stomach — is it the medication or is it nerves? Both, probably.

This guide maps the first 72 hours after a starting dose of semaglutide (0.25 mg) or tirzepatide (2.5 mg) so you know what's happening, what's normal, and what would actually warrant a call to your prescriber. Everything here reflects published prescribing information, clinical trial safety data, and the patterns clinicians report seeing most often in practice.

Hours 0–4: Immediately After Injection

Hours 4–12: The Quiet Window

This stretch is usually uneventful. You might notice your appetite at the next meal is slightly blunted — meals feel satisfying sooner, or the thought of food carries less urgency. This is the GLP-1 mechanism working: the medication slows gastric emptying, meaning food stays in the stomach longer, and it acts centrally on appetite-regulation pathways in the hypothalamus.

If you're a tirzepatide patient, the dual GLP-1/GIP agonism means you may also notice a subtle shift in how you process glucose after eating — fewer energy crashes, more steady-state fullness. Many patients describe this as "the food noise turned down" rather than appetite disappearing entirely.

Hydration checkpoint: Start building the habit now. Aim for at least 64 ounces of water across the day. GLP-1 receptor agonists can contribute to dehydration through reduced fluid intake (you eat less, and food contains water) and occasional GI effects. Dehydration is behind many of the symptoms patients blame on the medication itself.

Hours 12–24: First Potential Side Effects

If GI effects are going to show up on a starting dose, this is typically when they begin. The STEP and SURMOUNT trials documented the following side-effect rates at starting doses (not maintenance doses — those numbers are higher):

Nausea: Reported by roughly 15–20% of semaglutide patients and 12–18% of tirzepatide patients at starting dose. It's usually mild — a low-grade queasiness, not vomiting. Eating small, bland meals and avoiding high-fat foods reduces it significantly. If you feel genuinely nauseated, ginger tea or ginger chews are the most commonly recommended first-line intervention. Avoid lying flat; a slight incline helps gastric motility.

Fatigue: About 5–10% of patients report unusual tiredness in the first 24 hours. This tends to resolve by day two or three and often correlates with reduced caloric intake rather than a direct drug effect.

Headache: Mild headache occurs in roughly 10–14% of patients. It's almost always dehydration-related. If you're drinking enough water and the headache persists past 24 hours, acetaminophen is safe to take. Avoid NSAIDs until you're consistently well-hydrated — the combination of GLP-1s, reduced fluid intake, and NSAIDs can strain kidneys.

Injection site reaction: A small, itchy bump at the injection site may develop. It's a local immune reaction to the depot, not an allergy to the medication. It resolves on its own. If the area spreads larger than your palm, becomes hot, or develops streaking — call your provider.

Hours 24–48: The Adjustment Period

By the end of the first day, the medication has reached meaningful plasma levels. This is where the appetite-suppression effect becomes unmistakable for most patients. Meals that would normally take 15 minutes to finish may feel complete in 8. The thought of snacking between meals may simply not occur to you.

This is where the most common mistake happens: patients dramatically under-eat. On a starting dose, your body still needs adequate nutrition. Skipping meals because you "don't feel hungry" leads to fatigue, irritability, brain fog, and muscle catabolism — exactly the outcomes you're trying to avoid. Clinicians recommend eating at scheduled intervals even when appetite is low: at minimum, three meals per day with at least 60–80 grams of protein total.

If nausea appeared in the first 24 hours, it typically peaks somewhere in the 24–48 hour window and then begins improving. The trajectory matters more than the intensity — nausea that's getting steadily worse after 48 hours is different from nausea that peaked and is now fading.

Constipation watch

Delayed gastric emptying means the entire GI transit time slows down. About 10–15% of patients report constipation within the first week. Start a mild prevention strategy now rather than waiting for it to become a problem: adequate fiber (25–30g/day), plenty of water, and physical activity. If three days pass without a bowel movement, an over-the-counter osmotic laxative like polyethylene glycol (MiraLAX) is the standard clinician recommendation — stimulant laxatives are second-line.

Hours 48–72: Settling In

By the third day, most patients have a clear picture of how this starting dose affects them. You fall into one of three common patterns:

The quiet responder (about 50–60% of patients): Minimal side effects, noticeable appetite reduction, slight increase in satiety. You wonder if the medication is "working" because you expected more dramatic changes. It is working — the starting dose is intentionally sub-therapeutic for weight loss. Its purpose is acclimation. The weight-loss dose comes later, after titration.

The GI-sensitive responder (about 25–30%): Nausea and/or other GI symptoms appeared, peaked around 24–48 hours, and are now improving or stable. This is the normal trajectory. Clinicians expect these symptoms to resolve within 5–7 days as your GLP-1 receptors adapt to the medication.

The high responder (about 10–15%): Strong appetite suppression and potentially significant nausea even on a starting dose. If you're barely able to eat, contact your prescriber — they may recommend a slower titration schedule or dietary adjustments. Strong response to the starting dose often predicts strong overall efficacy, but it needs to be managed so you don't become dehydrated or malnourished during acclimation.

The 72-Hour Checklist

Before your first week ends, use this checkpoint to assess where you stand:

Hydration: Are you consistently drinking 64+ ounces of water per day? Dehydration amplifies every side effect.

Protein intake: Are you hitting at least 60 grams per day? Low protein intake on GLP-1s leads to accelerated lean mass loss — the single most important dietary variable to manage.

Side effect trajectory: If nausea or other GI symptoms appeared, are they improving, stable, or worsening? Improving or stable = expected. Worsening after 72 hours = call your prescriber.

Injection site: Is the site resolving normally? A small bump or bruise is fine. Heat, expanding redness, or streaking is not.

Mood and energy: Are you eating enough to maintain your baseline energy? Profound fatigue on a starting dose almost always traces back to inadequate caloric intake, not the medication itself.

When Something Is Not Normal

The starting dose is deliberately low, and serious adverse events at starting doses are rare in clinical trial data. But certain symptoms warrant immediate attention regardless of dose:

Call your prescriber promptly if you experience: persistent vomiting (not just nausea) that prevents you from keeping liquids down for more than 12 hours; severe abdominal pain (not mild cramping) that is constant and worsening; signs of pancreatitis — sharp, boring pain in the upper abdomen that radiates to the back; signs of an allergic reaction — hives, swelling of the face/lips/tongue, difficulty breathing.

These are rare on starting doses, but they exist in the prescribing information for a reason. Don't talk yourself out of calling because you "just started" and think it's too soon for problems. Clinicians would rather get a call about nothing than miss something early.

Looking Ahead: What Happens After 72 Hours

The first week continues the acclimation pattern. Most side effects that appeared resolve by days 5–7. Your appetite suppression will remain at roughly this level until your next dose (weekly for both semaglutide and tirzepatide in standard protocols). Some patients notice appetite returning slightly in the 24–48 hours before their next injection — this is normal and does not indicate the medication has stopped working.

Your prescriber will keep you at the starting dose for at least 4 weeks (semaglutide) or 4 weeks (tirzepatide) before considering titration upward. This is not conservative — it's the label-recommended schedule. Every titration step repeats a version of this 72-hour adjustment, though most patients find subsequent titrations milder than the first because their GLP-1 receptors have already begun adapting.

The single best predictor of long-term success with GLP-1 therapy is consistency: taking the medication on schedule, maintaining adequate protein, staying hydrated, and communicating with your prescriber when something doesn't feel right. The first 72 hours are just the beginning of that pattern.